These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 29087163)

  • 1. [USE OF STATINS IN PATIENTS WITH CHRONIC KIDNEY DISEASE TO PREVENT CARDIOVASCULAR DISEASE].
    Zavidić T; Lodeta B; Lovrinić Đ
    Acta Med Croatica; 2016 Dec; 70(4-5):301-7. PubMed ID: 29087163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statins can improve proteinuria and glomerular filtration rate loss in chronic kidney disease patients, further reducing cardiovascular risk. Fact or fiction?
    Athyros VG; Katsiki N; Karagiannis A; Mikhailidis DP
    Expert Opin Pharmacother; 2015; 16(10):1449-61. PubMed ID: 26037614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statins in chronic kidney disease: cardiovascular risk and kidney function.
    Deedwania PC
    Postgrad Med; 2014 Jan; 126(1):29-36. PubMed ID: 24393749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Chronic Kidney Disease on Risk for Vascular Events.
    Fan J; Salameh H
    Curr Vasc Pharmacol; 2016; 14(5):409-414. PubMed ID: 27456102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment options for dyslipidemia in chronic kidney disease and for protection from contrast-induced nephropathy.
    Athyros VG; Tziomalos K; Karagiannis A
    Expert Rev Cardiovasc Ther; 2015; 13(9):1059-66. PubMed ID: 26206619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of atorvastatin on renal function in patients with dyslipidemia and chronic kidney disease: assessment of clinical usefulness in CKD patients with atorvastatin (ASUCA) trial.
    Kimura G; Kasahara M; Ueshima K; Tanaka S; Yasuno S; Fujimoto A; Sato T; Imamoto M; Kosugi S; Nakao K
    Clin Exp Nephrol; 2017 Jun; 21(3):417-424. PubMed ID: 27392909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of statins on renal function.
    Agarwal R
    Mayo Clin Proc; 2007 Nov; 82(11):1381-90. PubMed ID: 17976359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of statin therapy on cardiovascular and renal outcomes in patients with chronic kidney disease: a systematic review and meta-analysis.
    Hou W; Lv J; Perkovic V; Yang L; Zhao N; Jardine MJ; Cass A; Zhang H; Wang H
    Eur Heart J; 2013 Jun; 34(24):1807-17. PubMed ID: 23470492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statins in chronic kidney disease and kidney transplantation.
    Kassimatis TI; Goldsmith DJ
    Pharmacol Res; 2014 Oct; 88():62-73. PubMed ID: 24995940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Should we use statins in all patients with chronic kidney disease without dialysis therapy? The current state of knowledge.
    Rysz J; Gluba-Brzózka A; Banach M; Więcek A
    Int Urol Nephrol; 2015 May; 47(5):805-13. PubMed ID: 25758011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Statins: what is their place in the treatment of chronic kidney insufficiency?].
    Ponte B; Bourquin V; Stoermann-Chopard C
    Rev Med Suisse; 2009 Feb; 5(192):463-4, 466-8. PubMed ID: 19317313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence-based statin prescription for cardiovascular protection in renal impairment.
    Fabbian F; De Giorgi A; Pala M; Tiseo R; Manfredini R; Portaluppi F
    Clin Exp Nephrol; 2011 Aug; 15(4):456-63. PubMed ID: 21556807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LDL-cholesterol lowering and renal outcomes.
    Waters DD
    Curr Opin Lipidol; 2015 Jun; 26(3):195-9. PubMed ID: 25887677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is lipid management effective for all stages of CKD?
    Ku E; Campese V
    Blood Purif; 2013; 35(1-3):26-30. PubMed ID: 23343543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Statins on Renal Outcome in Chronic Kidney Disease Patients: A Systematic Review and Meta-Analysis.
    Sanguankeo A; Upala S; Cheungpasitporn W; Ungprasert P; Knight EL
    PLoS One; 2015; 10(7):e0132970. PubMed ID: 26151753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in Statin Use Among US Adults With Chronic Kidney Disease, 1999-2014.
    Mefford MT; Rosenson RS; Deng L; Tanner RM; Bittner V; Safford MM; Coll B; Mues KE; Monda KL; Muntner P
    J Am Heart Assoc; 2019 Jan; 8(2):e010640. PubMed ID: 30651020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statins in the management of dyslipidemia associated with chronic kidney disease.
    Epstein M; Vaziri ND
    Nat Rev Nephrol; 2012 Feb; 8(4):214-23. PubMed ID: 22349484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Statins on Kidney Disease Outcomes: A Systematic Review and Meta-analysis.
    Su X; Zhang L; Lv J; Wang J; Hou W; Xie X; Zhang H
    Am J Kidney Dis; 2016 Jun; 67(6):881-92. PubMed ID: 26905361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology of dyslipidemia in chronic kidney disease.
    Iseki K
    Clin Exp Nephrol; 2014 Apr; 18(2):185-8. PubMed ID: 24408220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Etiology and management of dyslipidemia in children with chronic kidney disease and end-stage renal disease.
    Khurana M; Silverstein DM
    Pediatr Nephrol; 2015 Dec; 30(12):2073-84. PubMed ID: 25801207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.